Cost Analysis of Self-Monitoring Blood Glucose in Nonintensi

Analysis of claims data showed reduced utilization and costs among patients with nonintensively treated type 2 diabetes (T2D) using self-monitoring of blood glucose compared with continuous glucose monitoring.

Related Keywords

Switzerland , Italy , Bari , Puglia , United States , Rotkreuz , Switzerland General , Netherlands , American , Eli Lilly , Santa Clara , Santa Barbara , David Kerr , Diabetes Technology Society , Department Of Precision , Medtronic , Novo Nordisk , American Diabetes Association , Us Bureau Of Labor Statistics , Astrazeneca , Roche Diagnostics International Ltd , Health Care , American Diabetes Association Standards Of Care , Coalition For Clinical Research , D International Classification Of Diseases , Santa Barbara Actuaries Inc , Study Group , University Of Bari Aldo Moro , American Diabetes Association Professional Practice Committee , Boehringer Ingelheim , European Association For The Study Of Diabetes , Novartis , Merative Marketscan Commercial , International Classification , Tenth Revision , Clinical Modification , Charlson Comorbidity Index , Consumer Price , American Diabetes Association Standards , Roche Diabetes Care , Roche Molecular Systems , Regenerative Medicine , Ionian Area , Internal Medicine , Metabolic Diseases , Bari Aldo Moro , Roche Diabetes , European Association , Roche Diagnostics , Merck Sharp , Diabetes Association Professional Practice , Clinical Research Self Monitoring , Blood Glucose Scientific , Diabetes Sci , Res Clin , Medical Care , Accessed November , Diabetes , Blood Glucose , Cgm , T2d ,